Latest News Archive
Please select Category, Year, and then Month to display items
24 September 2024
|
Story Aimée Barlow
|
Photo Supplied
Louzanne Coetzee, who made history by clinching South Africa’s second medal at the Paralympics, earning a bronze in the T11 1 500 m women’s final with a personal best time, received a warm reception when she recently returned home.
The celebrated Paralympic bronze medallist Louzanne Coetzee returned home to a warm welcome at the Bram Fischer International Airport on 10 September 2024.
Family, friends, colleagues, Arista students, and media gathered to celebrate her remarkable achievement and show their support.
Coetzee – KovsieSport Coordinator of Parasport at the University of the Free State (UFS) – made history by clinching South Africa’s second medal at the Paralympics, earning a bronze in the T11 1 500 m women’s final with a personal best time. Her dedication and hard work have not only brought her personal glory but have also inspired many in her community.
Among those present to welcome her was Jerry Laka, Director of KovsieSport, who expressed his pride in Coetzee’s accomplishments.
"We as KovsieSport are so proud of our colleague Coetzee. It is amazing to see a product of KovsieSport achieving greatness on the world stage. She is truly an inspiration to us all," said Laka.
“I am so glad to be back, and to have Laka and my colleagues here. It means the world to me. Having Laka here shows his commitment to my career and ParaSport and his staff in general,” shared Coetzee, her gratitude evident.
She further expressed her appreciation for the support she received, stating, “I don’t have the words to describe how thankful I am for the support from the UFS community.”
Coetzee’s return is a proud moment for South Africa and the University of the Free State (UFS) community. Welcome home, Louzanne! Your achievements have made us all proud!
UFS researcher explores the future cost of cancer
2017-01-10
Dr Alicia Sherriff, Head the Department of Oncology
at the UFS Faculty of Health Sciences, co-authored
an article in the South African Medical Journal.
Photo: Charl Devenish
Cancer is on an exponential rise globally, and the cost of treatment is a growing international problem. South Africa alone is expected to see a 78% increase in cancer cases. Dr Alicia Sheriff, Head of the Department of Oncology, collaborated on and co-authored a research paper for the South African Medical Journal on the future of oncology treatment in the country, along with doctors from various universities across South Africa. The article, titled "The future cost of cancer: interdisciplinary cost management strategy", looks at the prognosis of cancer management in the country.
Cancer is on the rise
There is a visible growth of the cancer disease in the developing world. Rapidly changing lifestyles, uncontrolled urbanisation, pollution, and population ageing are some dynamics that provide a lethal cocktail of infectious and lifestyle risk factors that leave people at a higher risk of developing cancer.
The simultaneous increase in cancer incidence has increased the cost of treatment exponentially. The cost of cancer treatment is multitiered, making the provision of care for cancer patients a high-risk business. A combination of treatment delays, limited resources, differently skilled personnel, high patient volumes and advanced disease stage on presentation all place a bigger burden on the delivery of optimal cancer care outcomes.
Adoption of new strategies
According to the doctors, innovative thinking to embrace technology, combined with a preventive approach, as well as lowering the cost of treatment drugs should be prioritised. So should the commercialisation of new technologies that will diagnose and treat cancer in its early stages. They also encourage interdisciplinary research funding in South Africa as a way to better understand the demographic and molecular dynamics of cancer in the country, along with retaining more oncologists in the public health sector.
Efficient solutions to curb cancer mortality
The doctors assert there is a need to continue to look for more efficient measures to best treat the disease, and hopefully bring about a change in mortality levels in South Africa.